Search
-
News
Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.
… Wednesday, January 26, 2022 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State ’s 2022 Health Care Power 100 list . The prestigious Health Care Power list recognizes the most influential public health officials, hospital executives
-
Merkel Cell Carcinoma
Visit now learn about and meet our team of Merkel cell carcinoma doctors, surgeons and other experts, including their education, training, board certifications, publications, and specific areas of expertise.
… At Memorial Sloan Kettering Cancer Center, our Merkcel cell carcinoma and skin cancer team include specialists in surgery, head and neck cancers, radiation oncology, medical oncology, and dermatology. Each team member has expertise in evaluating and treating patients with cancers of the skin — including
-
-
News
A new study from Kenneth Offit, MD, Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with advanced cancer are not detected using traditional methods based on family history.
… Tuesday, September 5, 2017 Bottom Line A new study from Kenneth Offit, MD , Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with
-
-
Biostatistics
… Software Contributors Mithat Gönen References Planning a Dose-Response Study with Subject-Specific Doses. Statistics in Medicine 2005 Sep 15;24(17):2613-23.
-
Clinical Trial
… Full Title Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial) (NRG-GU014) (CIRB) Purpose Researchers are comparing two treatments for people with non-muscle invasive bladder cancer. If you take part in this
-
Patient & Caregiver Education
تساعدك هذه المعلومات في تَعلُّم كيفية إعطاء نفسك حقنة فيلجراستيم (Neupogen) أو بيجفيلجراستيم (Neulasta) تحت الجلد باستخدام محقن مُعبأ مسبقًا.
… تساعدك هذه المعلومات في تعلم كيفية إعطاء نفسك حقنة فيلجراستيم (Neupogen) أو بيجفيلجراستيم (Neulasta) تحت الجلد باستخدام محقن مُعبأ مسبقًا. تُعطَى هذه الحقنة تحت الجلد. المحقن المُعبأ مسبقًا هو عبارة عن محقن يحتوي بداخله على الدواء. سيوضح لك مقدم الرعاية الصحية كيفية إعطاء نفسك حقنة تحت الجلد. يمكنك استخدام
-
Patient & Caregiver Education
This information will teach you how to give yourself a subcutaneous (below the skin) injection with filgrastim (Neupogen) or pegfilgrastim (Neulasta) using a prefilled syringe.
… This information will teach you how to give yourself a subcutaneous (SUB-kyoo-TAY-nee-us) injection (shot) with filgrastim (Neupogen) or pegfilgrastim (Neulasta) using a prefilled syringe. A subcutaneous injection is an injection that is given under your skin. A prefilled syringe is a syringe that comes
-
Patient & Caregiver Education
En este documento se le enseñará a autoadministrarse una inyección subcutánea (debajo de la piel) de filgrastim (Neupogen) o pegfilgrastim (Neulasta) con una jeringa prellenada.
… En este documento se le enseñará a autoadministrarse una inyección (vacuna) subcutánea de filgrastim (Neupogen) o pegfilgrastim (Neulasta) con una jeringa prellenada. Una inyección subcutánea es una inyección que se coloca debajo de la piel. Una jeringa prellenada es una jeringa que viene con medicamento